Foresee Pharmaceuticals Co (ROCO:6576) Marketable Securities: NT$22.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6576 Foresee Pharmaceuticals Co Ltd ROCO:6576
65 GF Score
Price NT$79.70
GF Value NT$84.18
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Foresee Pharmaceuticals Co Marketable Securities?

Foresee Pharmaceuticals Co ROCO:6576 65 Marketable Securities is NT$22.0 Mil as of Mar. 2026. GuruFocus rates ROCO:6576 with a GF Score™ of 65/100 and a GF Value™ of NT$84.18 (Fairly Valued). The stock has 10 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Foresee Pharmaceuticals Co's Marketable Securities for the quarter that ended in Mar. 2026 was NT$22.0 Mil.

Foresee Pharmaceuticals Co's annual Marketable Securities declined from Dec. 2023 (NT$342.5 Mil) to Dec. 2024 (NT$75.0 Mil) but then increased from Dec. 2024 (NT$75.0 Mil) to Dec. 2025 (NT$220.7 Mil).

Foresee Pharmaceuticals Co  (ROCO:6576) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Foresee Pharmaceuticals Co Marketable Securities Related Terms

Foresee Pharmaceuticals Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Foresee Pharmaceuticals Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foresee Pharmaceuticals Co Marketable Securities Chart

Foresee Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 397.47 0.00 342.50 75.00 220.70

Foresee Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.00 75.00 125.00 220.70 21.96
ROCO:6576
65GF Score
Foresee Pharmaceuticals Co Ltd ROCO:6576
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Foresee Pharmaceuticals Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$22.0 Mil mean?
Foresee Pharmaceuticals Co (ROCO:6576) has a Marketable Securities of NT$22.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Foresee Pharmaceuticals Co and its competitors.
Is Foresee Pharmaceuticals Co's Marketable Securities too high?
Foresee Pharmaceuticals Co's current Marketable Securities is NT$22.0 Mil. Overall, Foresee Pharmaceuticals Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Foresee Pharmaceuticals Co's Marketable Securities compare to ZTS?
Foresee Pharmaceuticals Co's Marketable Securities of NT$22.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Foresee Pharmaceuticals Co and its competitors. Foresee Pharmaceuticals Co's current Marketable Securities is NT$22.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Foresee Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Foresee Pharmaceuticals Co (ROCO:6576) is currently considered Fairly Valued. The stock's GF Value™ is NT$84.18, compared to a current price of NT$79.70 — trading 5.3% below its estimated fair value. The current Marketable Securities is NT$22.0 Mil. Foresee Pharmaceuticals Co's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Foresee Pharmaceuticals Co (ROCO:6576), the current Marketable Securities is NT$22.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Foresee Pharmaceuticals Co (ROCO:6576) Overvalued in 2026?

Based on GuruFocus' analysis, Foresee Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$79.70 is trading 5.3% below its estimated GF Value™ of NT$84.18. GuruFocus considers Foresee Pharmaceuticals Co to be Fairly Valued.

Key valuation signals for ROCO:6576:

  • Marketable Securities: NT$22.0 Mil
  • GF Value™: NT$84.18 vs. price of NT$79.70 (5.3% below fair value)
  • GF Score™: 65/100 with 10 warning signs

No single metric tells the full story. See the ROCO:6576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Foresee Pharmaceuticals Co Business Description

Address No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115
Foresee Pharmaceuticals Co Ltd main activity is applying stabilized injectable formulation (SIF) platform technology to produce products for anticancer and treatment of chronic diseases. Its pipeline includes CAMCEVI (Leuprolide, FP-001), FP-014 (Triptorelin), Aderamastat (FP-025, MMP-12 Inhibitor), Linvemastat (FP-020, MMP-12 Inhibitor), and others. The Group operates business only in a single industry of new drug development, and all of its revenue is generated from Taiwan.
65GF Score

Get the complete analysis for ROCO:6576

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$79.70
Price
NT$84.18
GF Value